Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name DPX-Survivac
Trade Name
Drug Descriptions

DPX-Survivac is a liposome-encapsulated cancer vaccine that contains Survivin epitopes, which may induce an immune response against Survivin-expressing tumor cells (PMID: 26405584).

CAS Registry Number NA
NCIT ID C97951


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cyclophosphamide + DPX-Survivac Cyclophosphamide DPX-Survivac 0 1
Cyclophosphamide + DPX-Survivac + Epacadostat Cyclophosphamide DPX-Survivac Epacadostat 0 1
Cyclophosphamide + DPX-Survivac + Letrozole Cyclophosphamide DPX-Survivac Letrozole 0 1
Cyclophosphamide + DPX-Survivac + Pembrolizumab Cyclophosphamide DPX-Survivac Pembrolizumab 0 4
DPX-Survivac DPX-Survivac 0 2
DPX-Survivac + Letrozole DPX-Survivac Letrozole 0 1
DPX-Survivac + Pembrolizumab DPX-Survivac Pembrolizumab 0 2

Additional content available in CKB BOOST